Literature DB >> 18092951

Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.

Jitka Kuncová1, Michael Urban, Václav Mandys.   

Abstract

Alterations of CD44 glycoproteins have been shown to play an important role in progression of various malignancies, including urothelial cancer. We investigated expression patterns of CD44s and CD44v6 in transitional cell carcinoma (TCC) of the urinary bladder in relation to tumour grade, proliferative activity, and immunoreactivity for p53. The selected markers were detected immunohistochemically in 122 samples of TCC. We found a close relationship between CD44s and CD44v6 expression and tumour grade. The extension of positive staining for CD44s and CD44v6 towards the luminal surface was a predominant feature of differentiated carcinomas (grades 1 and 2), suggesting deranged maturation of cancer cells related to their neoplastic transformation. Heterogeneous expression of CD44s and CD44v6 predominated in poorly differentiated tumours (G3-4). However, areas of squamous differentiation within the high-grade tumours displayed strong immunoreactivity for both CD44s and CD44v6. The proliferative activity and p53 overexpression increased with the dedifferentiation of the tumour. The results of this study are discussed in relation to the significance of CD44 expression in TCC and to the explanation for controversial results reported in previous studies on the relationship between CD44 expression and the biological behaviour of urothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092951     DOI: 10.1111/j.1600-0643.2007.00602.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

Authors:  Katarzyna Marcinkiewicz; Kymora B Scotland; Stephen A Boorjian; Emeli M Nilsson; Jenny Liao Persson; Per Anders Abrahamsson; Cinzia Allegrucci; Ieuan A Hughes; Lorraine J Gudas; Nigel P Mongan
Journal:  Int J Oncol       Date:  2011-09-28       Impact factor: 5.650

2.  Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.

Authors:  Chandi Charan Mandal; Nayana Ghosh-Choudhury; Toshi Yoneda; Goutam Ghosh Choudhury; Nandini Ghosh-Choudhury
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

3.  Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.

Authors:  Wei-Chun Weng; Yu-Hui Huang; Shun-Fa Yang; Shian-Shiang Wang; Wu-Hsien Kuo; Chao-Wen Hsueh; Ching-Hsuan Huang; Ying-Erh Chou
Journal:  Tumour Biol       Date:  2015-12-12

4.  Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma.

Authors:  Han Suk Ryu; Sun Hoo Park; Kyung Bun Lee; Eun Shin; Ja-June Jang
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519

Review 5.  DNA damage in inflammation-related carcinogenesis and cancer stem cells.

Authors:  Shiho Ohnishi; Ning Ma; Raynoo Thanan; Somchai Pinlaor; Olfat Hammam; Mariko Murata; Shosuke Kawanishi
Journal:  Oxid Med Cell Longev       Date:  2013-12-05       Impact factor: 6.543

6.  Inflammation-Related DNA Damage and Cancer Stem Cell Markers in Nasopharyngeal Carcinoma.

Authors:  Shumin Wang; Ning Ma; Weilin Zhao; Kaoru Midorikawa; Shosuke Kawanishi; Yusuke Hiraku; Shinji Oikawa; Zhe Zhang; Guangwu Huang; Mariko Murata
Journal:  Mediators Inflamm       Date:  2016-08-28       Impact factor: 4.711

Review 7.  Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells.

Authors:  Shosuke Kawanishi; Shiho Ohnishi; Ning Ma; Yusuke Hiraku; Shinji Oikawa; Mariko Murata
Journal:  Genes Environ       Date:  2017-01-01

8.  The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.

Authors:  Yu Hu; Yongrui Zhang; Jialin Gao; Xin Lian; Yuantao Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer.

Authors:  Raynoo Thanan; Mariko Murata; Ning Ma; Olfat Hammam; Mohamed Wishahi; Tarek El Leithy; Yusuke Hiraku; Shinji Oikawa; Shosuke Kawanishi
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 10.  Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.

Authors:  Joaquim Bellmunt
Journal:  Biomedicines       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.